References
- Aftab U, Sajid I. 2017. Antitumor peptides from Streptomyces sp. SSA 13, isolated from Arabian sea. Int J Pept Res Ther. 23(2):199–211.
- Aftab U, Zechel DL, Sajid I. 2015. Antitumor compounds from Streptomyces sp. KML-2, isolated from Khewra salt mines, Pakistan. Biol Res. :48–58.
- Baker DD, Alvi KA. 2004. Small-molecule natural products: new structures, new activities. Curr Opin Biotechnol. 15(6):576–583.
- Baker S, Thomson N, Weill FX, Holt KE. 2018. Genomic insights into the emergence and spread of antimicrobial-resistant bacterial pathogens. Science. 360(6390):733.
- Barreiro C, Martínez-Castro M. 2019. Regulation of the phosphate metabolism in Streptomyces genus: impact on the secondary metabolites. Appl Microbiol Biotechnol. 103(4):1643–1658.
- da Rocha AB, Lopes RM, Schwartsmann G. 2001. Natural products in anticancer therapy. Curr Opin Pharmacol. 1(4):364–369.
- David MZ, Daum RS. 2010. Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev. 23(3):616–687.
- Demain AL. 2014. Importance of microbial natural products and the need to revitalize their discovery. J Ind Microbiol Biotechnol. 41(2):185–201.
- Demain AL, Sánchez S. 2018. Advancement of biotechnology by genetic modifications. Methods Mol Biol. 1852:1–43.
- Giddings LA, Newman DJ. 2013. Microbial natural products: molecular blueprints for antitumor drugs. J Ind Microbiol Biotechnol. 40(11):1181–1210.
- Gupte M, Kulkarni P, Ganguli BN. 2002. Antifungal antibiotics. Appl Microbiol Biotechnol. 58(1):46–57.
- Kim KJ, Kim MA, Jung JH. 2008. Antitumor and antioxidant activity of protocatechualdehyde produced from Streptomyces lincolnensis M-20. Arch Pharm Res. 31(12):1572–1577.
- Li G, Lou HX. 2018. Strategies to diversify natural products for drug discovery. Med Res Rev. 38(4):1255–1294.
- Liu R, Deng ZX, Liu TG. 2018. Streptomyces species: ideal chassis for natural product discovery and overproduction. Metab Eng. 50:74–84.
- Mishra RP, Oviedo-Orta E, Prachi P, Rappuoli R, Bagnoli F. 2012. Vaccines and antibiotic resistance. Curr Opin Microbiol. 15(5):596–602.
- Shaffer SM, Dunagin MC, Torborg SR, Torre EA, Emert B, Krepler C, Beqiri M, Sproesser K, Brafford PA, Xiao M, et al. 2017. Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance. Nature. 546(7658):431
- Shelar DB, Shirote PJ. 2010. Natural product in drug discovery: back to future. Biomed Pharmacol J. 4:141–146.
- Singh SB, Pelaez F. 2008. Biodiversity, chemical diversity and drug discovery. Prog Drug Res. 65:143–174.
- Vicente MF, Basilio A, Cabello A, Peláez F. 2003. Microbial natural products as a source of antifungals. Clin Microbiol Infect. 9(1):15–32.
- Xu B, Chen W, Wu ZM, Long Y, Li KT. 2015. A novel and effective Streptomyces sp. N2 against various phytopathogenic fungi. Appl Biochem Biotechnol. 177(6):1338–1347.